Avantor CEO Michael Stubblefield Delivers “Just Another” Stellar Q3, Raises 2024 Free Cash Flow Guidance Again

Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 milli...

October 28, 2024 | Monday | Company results
Thermo Fisher CEO Marc N. Casper Highlights Strong Q3 2024 Results with $10.6 Billion Revenue and Breakthrough Innovations

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the third quarter ended September 28, ...

October 24, 2024 | Thursday | Company results
Sherry Shao, Rotating CEO of GenScript, Celebrates MSCI's A Rating for Improved ESG Performance

"The A rating from MSCI is a significant recognition of our improvement in ESG performance," said Sherry Shao, Rotating CEO of GenScript. "We believe that ...

October 14, 2024 | Monday | News
Sanofi Moves Toward Strategic Divestment, Negotiates 50% Stake Sale of Opella with CD&R

Sanofi  announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake in Opella, its cons...

October 11, 2024 | Friday | News
Aenitis Technologies Secures Major Funding to Transform Bioproduction with Advanced Acoustofluidic Technology

  Aenitis is set to transform the bioproduction industry by addressing the increasing need for scalable, cost-effective, and highly precise cell ...

October 10, 2024 | Thursday | News
Ex-Pfizer Titans Stand Firm, Defiantly Back CEO Amid Activist Investor Storm, Betting on a Bold Long-Term Gamble for Shareholder Value

In an exclusive statement released through Guggenheim Securities, LLC, former Pfizer CEO Ian Read and former CFO Frank D’Amelio addressed growing s...

October 10, 2024 | Thursday | Analysis
Merck Opens €290 Million State-of-the-Art Biosafety Testing Facility in Maryland, Accelerating Global Drug Development

Note: Merck operates as MilliporeSigma in North America.   Facility consolidates biosafety testing, analytical development, and cell bank manufact...

October 10, 2024 | Thursday | News
Cell Signaling Technology Launches InTraSeq™ for Revolutionary Single-Cell Protein and RNA Quantification

Simultaneously and reliably quantify proteins, including post-translational modifications (PTMs), in a single-cell RNA sequencing (RNA-seq) assay using...

October 09, 2024 | Wednesday | News
Symbiosis Expands with £1.2M Barclays-Financed Acquisition of New 20,000 Sq/Ft Stirling Facility to Boost High-Tech Medicine Production

    Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1...

October 09, 2024 | Wednesday | News
A*STAR and Flagship Pioneering Partner to Drive Breakthrough Innovation in Health and Sustainability with SGD100 Million Investment

Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Acceler...

October 03, 2024 | Thursday | News
Cytiva Opens Innovation Hub in Songdo, Set to Transform Biopharma Manufacturing in South Korea

The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility together with a customer experience lab. Operations of the manufac...

September 30, 2024 | Monday | News
Takara Bio Europe Launches Shasta™ Single-Cell System, Advancing High-Throughput Oncology Biomarker Discovery

Takara Bio Europe, a wholly owned subsidiary of Takara Bio Inc., announces the launch of the Shasta™ Single-Cell System at the 2024 Human Cell A...

September 27, 2024 | Friday | News
Telesis Bio and Beckman Coulter Life Sciences Partner to Create Scalable Biofoundries for Rapid, High-Fidelity DNA Synthesis

A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient a...

September 26, 2024 | Thursday | News
Genespire Secures €46.6M Series B to Propel First Pediatric Gene Therapy into Clinical Trials

Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the la...

September 25, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close